Nanomedicine against antimicrobial resistance: mechanistic insights and next-generation therapeutic potential.

IF 5.3 3区 化学 Q2 CHEMISTRY, MULTIDISCIPLINARY
Frontiers in Chemistry Pub Date : 2026-09-14 eCollection Date: 2026-01-01 DOI:10.3389/fchem.2026.1915145
Vishal L Handa, Benedict B Vyas, Abhishek Padhi, Ashwini Agarwal, B R M Vyas
{"title":"Nanomedicine against antimicrobial resistance: mechanistic insights and next-generation therapeutic potential.","authors":"Vishal L Handa, Benedict B Vyas, Abhishek Padhi, Ashwini Agarwal, B R M Vyas","doi":"10.3389/fchem.2026.1915145","DOIUrl":null,"url":null,"abstract":"<p><p>Antimicrobial resistance (AMR) has emerged as one of the most critical global health threats, severely limiting the effectiveness of existing therapies against bacterial, fungal, and viral infections. The increasing prevalence of multidrug-resistant pathogens is largely driven by rapid genetic evolution, which promotes multiple resistance mechanisms such as drug degradation, target-site alteration, reduced intracellular drug accumulation, and biofilm formation, leading to persistent infections and rising mortality. These challenges highlight the urgent need for alternative therapeutic strategies beyond conventional antimicrobials. Nanomedicine has gained considerable attention due to its unique physicochemical properties, enabling improved drug stability, targeted delivery, controlled release, enhanced pathogen penetration, and multimodal antimicrobial action. This review comprehensively examines resistance mechanisms across major microbial pathogens and discusses the evolution of nanomedicine as an advanced platform for combating AMR. Particular emphasis is placed on green biogenic synthesis of nanoparticles using biological resources, offering environmentally sustainable and biocompatible antimicrobial nanomaterials. The synergistic interactions between nanomaterials and conventional antimicrobial agents that enhance therapeutic efficacy and restore susceptibility in resistant pathogens. Emerging next-generation antimicrobial nanomedicine platforms, including biomimetic nanoparticles, antimicrobial peptide delivery systems, CRISPR-enabled nanocarriers, and stimuli-responsive systems, are also highlighted for their potential in precision infection management. Finally, key challenges involving toxicity, biosafety, microbiome disruption, environmental impact, manufacturing scalability, regulatory and clinical translation. Addressing these barriers will be essential for advancing safe and effective nanomedicine-based solutions against AMR.</p>","PeriodicalId":12421,"journal":{"name":"Frontiers in Chemistry","volume":"14 ","pages":"1915145"},"PeriodicalIF":5.3000,"publicationDate":"2026-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13617642/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Chemistry","FirstCategoryId":"92","ListUrlMain":"https://doi.org/10.3389/fchem.2026.1915145","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Antimicrobial resistance (AMR) has emerged as one of the most critical global health threats, severely limiting the effectiveness of existing therapies against bacterial, fungal, and viral infections. The increasing prevalence of multidrug-resistant pathogens is largely driven by rapid genetic evolution, which promotes multiple resistance mechanisms such as drug degradation, target-site alteration, reduced intracellular drug accumulation, and biofilm formation, leading to persistent infections and rising mortality. These challenges highlight the urgent need for alternative therapeutic strategies beyond conventional antimicrobials. Nanomedicine has gained considerable attention due to its unique physicochemical properties, enabling improved drug stability, targeted delivery, controlled release, enhanced pathogen penetration, and multimodal antimicrobial action. This review comprehensively examines resistance mechanisms across major microbial pathogens and discusses the evolution of nanomedicine as an advanced platform for combating AMR. Particular emphasis is placed on green biogenic synthesis of nanoparticles using biological resources, offering environmentally sustainable and biocompatible antimicrobial nanomaterials. The synergistic interactions between nanomaterials and conventional antimicrobial agents that enhance therapeutic efficacy and restore susceptibility in resistant pathogens. Emerging next-generation antimicrobial nanomedicine platforms, including biomimetic nanoparticles, antimicrobial peptide delivery systems, CRISPR-enabled nanocarriers, and stimuli-responsive systems, are also highlighted for their potential in precision infection management. Finally, key challenges involving toxicity, biosafety, microbiome disruption, environmental impact, manufacturing scalability, regulatory and clinical translation. Addressing these barriers will be essential for advancing safe and effective nanomedicine-based solutions against AMR.

抗微生物耐药性的纳米药物:机制见解和下一代治疗潜力。
抗菌素耐药性(AMR)已成为全球最严重的健康威胁之一,严重限制了现有治疗方法对抗细菌、真菌和病毒感染的有效性。多药耐药病原体的日益流行在很大程度上是由快速的遗传进化驱动的,遗传进化促进了多种耐药机制,如药物降解、靶点改变、细胞内药物积累减少和生物膜形成,从而导致持续感染和死亡率上升。这些挑战突出表明迫切需要在常规抗微生物药物之外寻找替代治疗策略。纳米医学由于其独特的物理化学性质,能够改善药物稳定性,靶向递送,控制释放,增强病原体渗透和多模态抗菌作用而受到广泛关注。这篇综述全面研究了主要微生物病原体的耐药机制,并讨论了纳米医学作为对抗抗生素耐药性的先进平台的发展。特别强调的是绿色生物合成纳米粒子利用生物资源,提供环境可持续和生物相容性的抗菌纳米材料。纳米材料与传统抗菌剂之间的协同相互作用可增强耐药病原体的治疗效果并恢复其敏感性。新兴的下一代抗菌纳米药物平台,包括仿生纳米颗粒、抗菌肽递送系统、crispr纳米载体和刺激响应系统,也因其在精确感染管理方面的潜力而受到重视。最后,主要挑战涉及毒性、生物安全、微生物群破坏、环境影响、制造可扩展性、监管和临床转化。解决这些障碍对于推进安全有效的抗抗生素耐药性纳米医学解决方案至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Chemistry
Frontiers in Chemistry Chemistry-General Chemistry
CiteScore
8.50
自引率
3.60%
发文量
1540
审稿时长
12 weeks
期刊介绍: Frontiers in Chemistry is a high visiblity and quality journal, publishing rigorously peer-reviewed research across the chemical sciences. Field Chief Editor Steve Suib at the University of Connecticut is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to academics, industry leaders and the public worldwide. Chemistry is a branch of science that is linked to all other main fields of research. The omnipresence of Chemistry is apparent in our everyday lives from the electronic devices that we all use to communicate, to foods we eat, to our health and well-being, to the different forms of energy that we use. While there are many subtopics and specialties of Chemistry, the fundamental link in all these areas is how atoms, ions, and molecules come together and come apart in what some have come to call the “dance of life”. All specialty sections of Frontiers in Chemistry are open-access with the goal of publishing outstanding research publications, review articles, commentaries, and ideas about various aspects of Chemistry. The past forms of publication often have specific subdisciplines, most commonly of analytical, inorganic, organic and physical chemistries, but these days those lines and boxes are quite blurry and the silos of those disciplines appear to be eroding. Chemistry is important to both fundamental and applied areas of research and manufacturing, and indeed the outlines of academic versus industrial research are also often artificial. Collaborative research across all specialty areas of Chemistry is highly encouraged and supported as we move forward. These are exciting times and the field of Chemistry is an important and significant contributor to our collective knowledge.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书